A multicenter, randomized study of a combination therapy for patients with early rheumatoid arthritis

If you were told less than one year ago that you have rheumatoid arthritis, you may be eligible to participate in an international, 18-month research study of an investigational combination of medication currently used for rheumatoid arthritis.

You may be eligible to participate in this study if you:

• Are at least 18 years of age
• Were diagnosed with rheumatoid arthritis less than a year ago
• Have not used anti-TNF (tumor necrosis factor)
• Have not previously used methotrexate

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.